| 36th week of 2013 patent applcation highlights part 29 |
| Patent application number | Title | Published |
|---|
| 20130230556 | HERPESVIRUS OF TURKEYS VECTORED VACCINE AGAINST AVIAN INFLUENZA IN POULTRY - The present application applies to the field of veterinary vaccines, in particular of vaccines for poultry against avian influenza. The vaccine is based on a recombinant viral vector expressing the haemagglutinin protein of an influenza virus, wherein the vector is herpes virus of turkeys (HVT) and the haemagglutinin gene is driven by a glycoprotein B gene promoter from a mammalian herpesvirus. A vaccine comprising this HVT+HA vector can be used to induce a protective immune response against avian influenza in poultry, and to reduce the spread of AIV. The invention also relates to methods, uses, and vaccines involving the HVT+HA vector. | 2013-09-05 |
| 20130230557 | RECOMBINANT MICROORGANISMS AND USES THEREOF - The present invention relates to recombinant strains of | 2013-09-05 |
| 20130230558 | ONE DOSE VACCINATION AGAINST MYCOPLASMA INFECTIONS OF PIGS - The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by | 2013-09-05 |
| 20130230559 | NOVEL TACROLIMUS ANALOGUES, A NEUROPROTECTIVE COMPOSITION COMPRISING THE SAME, AN IMMUNOSUPPRESSIVE COMPOSITION COMPRISING THE SAME, A METHOD FOR PREPARING THE SAME, AND A MUTANT FOR PRODUCING THE SAME - The present invention relates to novel tacrolimus analogues, a composition for the prevention or treatment of neurological diseases or immune hypersensitivity disorders comprising the same, a method for preventing or treating neurological diseases or immune hypersensitivity disorders comprising administering the analogues to a subject, a method for preparing the analogues using an isolated modified | 2013-09-05 |
| 20130230560 | IgA PRODUCTION PROMOTER - To provide an IgA production promoter capable of being easily ingested safely and continually, for example orally and capable of preventing infection by inhibiting the binding of pathogenic microorganisms to alimentary canal mucosa and preventing an allergic reaction by blocking the passage of allergen materials such as pollen and house dust through the wall of the alimentary tract. The present invention consists of an IgA production promoter comprising hydroxypropyl starch as an effective ingredient. The IgA production promoter of the present invention can be safely and continually ingested because the effective ingredient thereof is hydroxypropyl starch used in food and the like, and can prevent infection by inhibiting the binding of pathogenic microorganisms to alimentary canal mucosa and prevent an allergic reaction by blocking the passage of allergen materials such as pollen and house dust through the wall of the alimentary tract. | 2013-09-05 |
| 20130230561 | PLACENTAL TISSUE GRAFTS PRODUCED BY CHEMICAL DEHYDRATION/FREEZE-DRYING AND METHODS FOR MAKING AND USING THE SAME - Described herein are placental tissue grafts produced by chemical dehydration followed by freeze-drying the placental tissue to produce the tissue graft. The tissue grafts retain their biological properties preferably at the same level as the placental tissues before they are processed. The placental tissue grafts have numerous medical applications. Methods for making the tissue graft compositions are also described herein. | 2013-09-05 |
| 20130230562 | FUSION PROTEIN COMPRISING SMALL HEAT SHOCK PROTEIN, CAGE PROTEIN FORMED THEREBY, AND NOVEL USE THEREOF - The present invention relates to a fusion protein comprising small heat shock protein, a cage protein formed thereby, and novel use thereof, more particularly, a fusion protein comprising a small heat shock protein, a recognition site of a protease, and a histidine polymer, wherein the recognition site and the histidine polymer are sequentially linked to a carboxyl terminal of the small heat shock protein, a cage protein formed thereby, and novel use thereof. The fusion protein of the present invention, and a cage protein formed by the self-assembly properties of the fusion protein are not cytotoxic, and emits a fluorescence signal of about 20 to about 50 times higher comparing to a single peptide for the conventional molecular imaging, per unit protein. Additionally, cell permeability is very excellent, thereby to be effectively used as a biosensor or a bioactive material carrier. | 2013-09-05 |
| 20130230563 | Multifunctional Filler Granule - The invention relates to a filler granule comprising a matrix component ( | 2013-09-05 |
| 20130230564 | Semi-Crystalline Composition For Coating - The present invention provides a coating comprising a semi-crystalline polymer on an implantable device and methods of making and using the same. | 2013-09-05 |
| 20130230565 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON - The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof. | 2013-09-05 |
| 20130230566 | WOUND HEALING COMPOSITIONS AND ASSOCIATED METHODS - In one embodiment, the present disclosure provides a composition including an aqueous solution comprising about 1% to about 50% weight/volume poloxamer having the general formula HO(C | 2013-09-05 |
| 20130230567 | Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same - The present disclosure generally relates to nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. Other aspects of the invention include methods of making such nanoparticles. | 2013-09-05 |
| 20130230568 | Stable Formulations for Lyophilizing Therapeutic Particles - The entire contents of all patents, published patent applications, websites, and other references cited herein are hereby expressly incorporated herein in their entireties by reference. | 2013-09-05 |
| 20130230569 | COMPOSITIONS OF R(+) AND S(-) PRAMIPEXOLE AND METHODS OF USING THE SAME - Compositions of predetermined amounts of R(+) pramipexole and S(−) pramipexole and methods of using the same, including for the treatment and prevention of Parkinson's disease, are provided. | 2013-09-05 |
| 20130230570 | HOLLOW SILICA NANOSPHERES AND METHODS OF MAKING SAME - The disclosure provide hollow nanospheres and methods of making and using the same. The methods and compositions of the disclosure are useful for drug delivery and gene transfer. | 2013-09-05 |
| 20130230571 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE - The present disclosure provides a device for intracorporeal use which comprises an implant or a temporary device and at least one source of myolimus or a derivative thereof. The present disclosure also provides a method of inhibiting cell proliferation, inflammation or cytokine production by systemic or local administration of a therapeutically effective amount of myolimus or a derivative thereof. Further included in the present disclosure is a method of treating an ophthalmic condition or disease by administering a therapeutically effective amount of myolimus or a derivative thereof. | 2013-09-05 |
| 20130230572 | Biocompatible and Biodegradable Composite Material for Use in Surgery and Process for Production Thereof - Composite biomaterials are described, which can be implanted in the human body in various branches of surgery or on the skin in dermocosmetic surgery, which can be formed as membranes or felts and which have properties of rate of absorption in the body and of hydrophilicity that can be modulated. | 2013-09-05 |
| 20130230573 | COLLAGEN STRUCTURES AND METHOD OF FABRICATING THE SAME - A method of fabricating a collagen structure, is disclosed. The method comprises applying onto a surface in a layerwise manner acidic solutions of liquid crystalline collagen and a crosslinker to form a layered structure. The acidic solutions that correspond to at least two adjacent layers have different concentrations of the crosslinker therein. | 2013-09-05 |
| 20130230574 | PROCESS FOR PREPARING POLYUREA MICROCAPSULES - The present invention relates to a process for producing perfume-containing microcapsules with a polyurea wall that can be used in home or personal care products, as well as to the microcapsules themselves and consumer products that contain these microcapsules. The process of the invention uses a combination of aromatic and aliphatic polyisocyanates in specific relative concentrations. | 2013-09-05 |
| 20130230575 | PARTICULATE WOOD PRESERVATIVE AND METHOD FOR PRODUCING THE SAME - A wood preservative includes injectable particles comprising one or more sparingly soluble copper salts. The copper-based particles are sufficiently insoluble so as to not be easily removed by leaching but are sufficiently soluble to exhibit toxicity to primary organisms primarily responsible for the decay of the wood. Exemplary particles contain for example copper hydroxide, basic copper carbonate, copper carbonate, basic copper sulfates including particularly tribasic copper sulfate, basic copper nitrates, copper oxychlorides, copper borates, basic copper borates, and mixtures thereof. The particles typically have a size distribution in which at least 50% of particles have a diameter smaller than 0.25 μm, 0.2 μm, or 0.15 μm. At least about 20% and even more than 75% of the weight of the particles may be composed of the substantially crystalline copper salt. Wood or a wood product may be impregnated with copper based particles of the invention. | 2013-09-05 |
| 20130230576 | MICROLAYER COEXTRUSION TO CREATE A TIME-RELEASE DRUG - Medical devices containing time release drug substance are disclosed, including medical tubing, catheters, stents, cables (including fiber optic cables), pills, capsules, sheaths, threads, clamps, sutures, and endotracheal devices. A method for extruding multiple laminated flow streams using microlayer coextrusion to create various time release drug delivery products is also disclosed. | 2013-09-05 |
| 20130230577 | SLOW-RELEASE FORMULATIONS OF 5-HYDROXYTRYPTOPHAN AS AN ADJUNCT TO PRO-SEROTONERGIC THERAPIES - The present invention concerns the treatment of serotonergic dysregulation disorders and/or augmentation of serotonin levels in the brain by add-on treatments to serotonin enhancers, and slow-release formulations of 5-hydroxytryptophan (5-HTP) therefor. | 2013-09-05 |
| 20130230578 | LIPIDATED IMMUNE RESPONSE MODIFIER COMPOUND COMPOSITIONS, FORMULATIONS, AND METHODS - The compound N-(4-{[4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl]oxy}butyl)octadecanamide is a useful drug compound for enhancing immune response and can be used, for example, as a vaccine adjuvant and a cancer treatment. | 2013-09-05 |
| 20130230579 | IMMUNOGENIC COMPOSITION COMPRISING NEISSERIA MENIGITIDIS MACROPHAGE INFECTIVITY POTENTIATOR PROTEIN - An immunogenic composition comprising the Nm-MIP protein or an immunogenic part thereof or an analogue thereof, wherein the composition is capable of eliciting an immune response when administered to a human or non-human animal, and uses thereof. A pharmaceutical composition or a vaccine composition comprising the Nm-MIP protein or an immunogenic part thereof or an analogue thereof. | 2013-09-05 |
| 20130230580 | Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration - Provided are therapeutics, uses and methods in which neuro-regenerative therapy using neuroprotective agents, or anti-neuropathic agents, to prevent loss or restore hematopoietic capacity and progenitor mobilization. | 2013-09-05 |
| 20130230581 | EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE - The present invention relates to the use of epidermal growth factor receptor (EGFR) antagonists in methods and compositions useful for the treatment of heart disease in a subject. In one embodiment, the methods of the present invention comprise: (a) administering to the subject an EGFR antagonist; and (b) inhibiting or substantially inhibiting the EGFR signal transduction cascade. In another embodiment the method of the present invention may be used in combination with another heart disease therapy. | 2013-09-05 |
| 20130230582 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES - Drug derivatives are provided herein which are suitable for loading into liposomal nanoparticle carriers. In some preferred aspects, the derivatives comprise a poorly water-soluble drug derivatized with a weak-base moiety that facilitates active loading of the drug through a LN transmembrane pH or ion gradient into the aqueous interior of the LN. The weak-base moiety can optionally comprise a lipophilic domain that facilitates active loading of the drug to the inner monolayer of the liposomal membrane. Advantageously, LN formulations of the drug derivatives exhibit improved solubility, reduced toxicity, enhanced efficacy, and/or other benefits relative to the corresponding free drugs. | 2013-09-05 |
| 20130230583 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES - Drug derivatives are provided herein which are suitable for loading into liposomal nanoparticle carriers. In some preferred aspects, the derivatives comprise a poorly water-soluble drug derivatized with a weak-base moiety that facilitates active loading of the drug through a LN transmembrane pH or ion gradient into the aqueous interior of the LN. The weak-base moiety can optionally comprise a lipophilic domain that facilitates active loading of the drug to the inner monolayer of the liposomal membrane. Advantageously, LN formulations of the drug derivatives exhibit improved solubility, reduced toxicity, enhanced efficacy, and/or other benefits relative to the corresponding free drugs. | 2013-09-05 |
| 20130230584 | TREATING BLADDER TUMOR CELLS USING FIBRONECTIN ATTACHMENT PROTEIN AS A TARGET - Composition and methods are disclosed for utilizing micro-aggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder. | 2013-09-05 |
| 20130230585 | PHARMACEUTICAL COMPOUNDS - Provided herein is a pharmaceutical composition that comprises a pharmaceutically acceptable carrier or diluent and, as an active ingredient, the compound 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine bismesylate. | 2013-09-05 |
| 20130230586 | Treatment of Tinnitus and Related Auditory Dysfunctions - The invention provides an extended-release dosage form of cyclobenzaprine for use in the treatment of tinnitus and related auditory dysfunctions by once-a-day oral administration, wherein the dosage form is a tablet or capsule comprising cyclobenzaprine as active agent in an amount from 10-80 mg, preferably from 10-60 mg. The active agent is associated with a polymer coating or matrix that comprises a water-insoluble polymer, the polymer coating or matrix providing the dosage form with an extended release of the active agent over at least 12 hours and preferably over at least 16 hours when the dosage form is administered to a patient. | 2013-09-05 |
| 20130230587 | SUSTAINED RELEASE COMPOSITIONS - Sustained release compositions comprising plurality of sustained release beads are disclosed. Particularly the sustained release beads comprise coated drug-resin complexes comprising drug-resin complexes of at least one active agent and at least one ion-exchange resin; coated with at least one release modifier. | 2013-09-05 |
| 20130230588 | CONTROLLED RELEASE COMPOSITIONS - An improved composition for controlling the release profile of an active compound through the intestinal tract comprises particles, especially pellets, containing the active compound, which are coated with a pH dissolution dependent coating material or a polymethacrylate material, which is preferably pH dissolution dependent, to a certain thickness depending upon the location and rate of release of the active compound that is desired. In preferred compositions, two or more pluralities of particles, in which particles of each plurality are coated with pH dissolution dependent coating material or polymethacrylate material to a different thickness to those of each other plurality, are contained within an enterically coated capsule and provide release of the active compound at various desired locations in the intestinal tract. | 2013-09-05 |
| 20130230589 | PHARMACEUTICAL FORMULATIONS USEFUL IN THE TREATMENT OF INSOMNIA - There is provided a formulation suitable for transmucosal administration comprising a short acting hypnotic drug, which formulation provides a measurable plasma concentration of drug within 10 minutes of administration. The formulation is capable of providing sleep on demand, and preferably comprises particles of drug, for example zolpidem or a pharmaceutically-acceptable salt thereof and a mucoadhesion promoting agent, such as sodium carboxymethylcellulose, which particles of drug and mucoadhesive are presented upon the surface of larger carrier particles. | 2013-09-05 |
| 20130230591 | PEPTIDE FOR USE AS A MEDICAMENT, IN PARTICULAR FOR THE TREATMENT OF CANCER - The invention relates to a peptide having the sequence SEQ.1: INWLKIAKKVAGML-NH2 and one or more of the variants thereof selected from among the sequences SEQ.2 to SEQ.25, or one of the mixtures thereof. The peptides are used especially as a medicament, in particular for the treatment of cancer. The invention also relates to a pharmaceutical composition including the peptides. | 2013-09-05 |
| 20130230592 | NOVEL OMEGA-3 AND OMEGA-6 FATTY ACID COMPOSITIONS AND USES THEREOF - A composition for use in preventing and/or treating and/or reducing organic, including symptomatic, mental disorders, comprising:
| 2013-09-05 |
| 20130230593 | Orally Dosed Pharmaceutical Compositions Comprising a Delivery Agent in Micronized Form - Solid pharmaceutical compositions and methods of their use suitable for the oral delivery of pharmacologically active agents, e.g. peptides, comprising a therapeutically-effective amount of a pharmacologically active agent; a crospovidone or povidone; and a delivery agent for said pharmacologically active agent are disclosed. The compositions utilize micronized forms of the delivery agent which provides enhanced bioavailability of pharmacologically active agents, particularly calcitonin. | 2013-09-05 |
| 20130230594 | COMPOSITIONS WITH ANTIBACTERIAL AND WOUND HEALING ACTIVITY - The present invention relates to compositions based on silver and hyaluronic acid and their use in the management of cutaneous lesions of various origin (acute and chronic wounds, ulcerations, burns, etc.) mainly when characterized by the presence of exudate and hence at high risk of infection. | 2013-09-05 |
| 20130230595 | Methods of Using Multilayer Magnetic Micelle Compositions - Provided herein is a method of transfecting a brain cell of a subject with a polynucleotide comprising systemically administering to the subject a composition comprising a micelle having a hydrophobic superparamagnetic iron oxide nanoparticle (SPION) core, a first coating comprising a cationic polymer, and a second coating comprising the polynucleotide, wherein the subject has a mild traumatic brain injury. | 2013-09-05 |
| 20130230596 | Abuse-Resistant Oral Dosage Forms And Method Of Use Thereof - An opioid-antagonist oral dosage form which does not release a therapeutically effective amount of the opioid antagonist when the oral dosage form is orally administered to a human being, but whereby a physical alteration of the oral dosage form results in a release of the therapeutically effective amount of the opioid antagonist. An embodiment of the oral dosage form includes an opioid-antagonist layer coated onto a biologically inert pellet, and a non-releasing membrane coated onto the opioid-antagonist layer. Optionally, the oral dosage form can also include an opioid agonist, such that a method of preventing the abuse of an oral dosage form of an opioid agonist is provided by forming the oral dosage form including an opioid agonist and an opioid antagonist. | 2013-09-05 |
| 20130230597 | ENTERIC-COATED SODIUM METABISULFITE LIVESTOCK FEED ADDITIVE FOR VOMITOXIN DETOXIFICATION - A livestock feed supplement in which a core particle containing sodium metabisulfite and at least one binder is enrobed with an enteric coating, wherein the thickness and composition of the coating protects the sodium metabisulfite from decomposition to sulfur dioxide in an aqueous acid stomach environment. Also disclosed are a method of delivering sodium metabisulfite to the lower gastrointestinal tract of an animal, and a method of delivering an antidote to relieve the toxic effect of vomitoxin in an animal, by administering to the animal the livestock feed supplement. | 2013-09-05 |
| 20130230598 | SUSTAINED-RELEASE COMPOSITION OF DRUGS ENCAPSULATED IN MICROPARTICLES OF HYALURONIC ACID - A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm. | 2013-09-05 |
| 20130230599 | Spray Dried Human Plasma - The technology relates to spray dried plasma and methods of making the same. The method includes providing plasma to a spray drying apparatus, spray drying the plasma, at the spray drying apparatus, to form physiologically active plasma power, the spray drying apparatus configured utilizing one or more parameters, and storing the physiologically active plasma powder. | 2013-09-05 |
| 20130230600 | THERAPEUTIC AGENT - Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions. | 2013-09-05 |
| 20130230601 | ISOLATED MESENCHYMAL PROGENITOR CELLS AND EXTRACELLULAR MATRIX PRODUCED THEREBY - Provided are methods of isolating an extracellular matrix from mesenchymal progenitor cells which are characterized by a reduced differentiation ability into an adipogenic lineage as compared to adipose-derived mesenchymal stem cells. Also provide isolated extracellular matrix and hybrid devices comprising electrospun elements and extracellular matrix which can be used for various tissue regeneration, repair and reconstruction surgeries. | 2013-09-05 |
| 20130230602 | Devices and Methods for Making and Administering an Intravenous Liquid with Supersaturated Dissolved Gas - Methods and devices for treating patients using high partial pressures of dissolved gas in a liquid. Greater than hyperbaric partial pressures of gas may be dissolved and maintained in the liquid when mixing occurs at ambient pressure. Additional increases in dissolved gas partial pressure may be achieved when the temperature of the liquid is further decreased. The method further includes administering the liquid intravenously via a conventional catheter. Gas exchange occurs due to diffusion upon mixing of the liquid and blood within the vasculature of the patient. | 2013-09-05 |
| 20130230603 | Polyheterosilxoanes For Antimicrobial Materials - Polyheterosiloxane compositions are disclosed containing at least 70% by weight of the following components: (A) a first metal (M1) selected from Ti, Zr, or Zn, (B) a second metal (M2), Zn, Cu, Bi, or Ag with the proviso that the second metal is not the same as the first metal, (C) siloxy units having the formula R′ | 2013-09-05 |
| 20130230604 | ORAL IRON DEFICIENCY THERAPY - Methods of normalizing iron levels, treating iron deficiency and disorders related thereto, such as anemia, as described. Pharmaceutical compositions effective for such treatments are also described. | 2013-09-05 |
| 20130230605 | Boron Compound Suspension - A suspension of a boron containing compound in the form of crystals, powder or granulate in a solvent which contain a carbomer as dispersant. This suspension is very stable, even at high concentrations, and exhibits favourable non-Newtonian viscosity behavior, which makes it suitable in a number of applications, such as for the control of fission reactions with the generation of electric power from nuclear energy. | 2013-09-05 |
| 20130230606 | METHODS AND COMPOSITIONS FOR REGULATING BIOFILM DEVELOPMENT - The present disclosure relates to methods for promoting dispersal of, or preventing formation of microbial biofilms, including: exposing a biofilm to an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent; treating a surface or medium susceptible to biofilm formation with an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent; incorporating an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent in a surface or medium susceptible to biofilm formation; or inducing the accumulation of one or more reactive oxygen or nitrogen species within microorganisms within said biofilm or capable of forming a biofilm. The disclosure also relates to methods for maintaining or enhancing or maintaining and enhancing the functioning of a biofilm, comprising exposing a biofilm to at least one nitric oxide scavenger, at least one antioxidant or at least one nitric oxide scavenger and at least one antioxidant. The disclosure also relates to compositions for promoting dispersal of, or preventing formation of microbial biofilms, or for maintaining or enhancing or maintaining and enhancing the functioning of microbial biofilms. | 2013-09-05 |
| 20130230607 | Method for Enhancing Sports Scores - Methods and compositions for enhancing the score of an individual in a sport activity are disclosed. | 2013-09-05 |
| 20130230608 | METHODS OF IMPROVING MENTAL OR PHYSICAL HEALTH CONDITIONS IN AN INDIVIDUAL - Methods of improving mental or physical health conditions of an individual are provided. In a general embodiment, the method provides administering to an individual in need of an improved mental or physical health condition a decaffeinated coffee product comprising an unroasted coffee. The mental or physical health condition can be, for example, sustained attention in the individual, improvement in the individual's mood or alertness, reduced headaches in the individual, and/or improved relaxation in the individual. | 2013-09-05 |
| 20130230609 | ANTIMICROBIAL/PRESERVATIVE COMPOSITIONS COMPRISING BOTANICALS - The present subject matter relates to a preservative or antimicrobial compositions which comprise low concentrations of botanical extracts, in synergistic combinations with alkanediols in a solvent system, optionally with fruit acids. Additionally, the present subject matter relates to a preservative or antimicrobial compositions which comprise a silver compound, an essential oil or individual constituent, one or more zinc salts, and one or more alkanediol. The compositions of the application may be used in personal care products including wound care products or in veterinary use. Preferably, the compositions of the application have little or no human-detectable fragrance. | 2013-09-05 |
| 20130230610 | TOPICAL SANITIZER AND METHOD OF USE WITH GLOVES - Topical sanitizer includes avenanthramides, which is an active component of oats that is beneficial to the skin. The topical sanitizer is used preferably in conjunction with gloves that have an inner coating that includes avenanthramides. By using topical sanitizer that includes avenanthramides before and after wearing gloves, the skin of the person wearing the glove is more exposed to the beneficial avenanthramides all during the workday, not just when wearing gloves. The result is healthier, much softer and more comfortable skin on the hands. | 2013-09-05 |
| 20130230611 | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS - The present invention generally relates to the field of probiotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic micro-organisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. | 2013-09-05 |
| 20130230612 | GLASS REPAIRER - A glass repairer of the present invention includes a support base for fixation, a fluid-receiving tube, a pressing rod, and a rubber head for injecting repairing fluid. The fluid-receiving tube is disposed on the support base. The rubber head is fixed to an end of the pressing rod and is able to squeeze the repairing fluid in the fluid-receiving tube outward. Thereby, replenishing repairing fluid and cleaning become easier. Also, the present invention is able to be utilized repeatedly. | 2013-09-05 |
| 20130230613 | APPARATUSES AND METHODS FOR OBTAINING AN OBJECT SUCH AS A SEAL, AND A SEAL FOR CONTAINERS - An apparatus for forming an object from plastics material includes a forming arrangement having a recess for forming an edge zone of the object, the recess extending around an internal region of the forming arrangement and a conduit cooperating with a piston device to supply the plastics material to the recess, the conduit leading into the internal region into a position contiguous with the recess. | 2013-09-05 |
| 20130230614 | FILM BLOWING HEAD - A film blowing head ( | 2013-09-05 |
| 20130230615 | APPARATUSES AND METHODS FOR MAKING SEAL RINGS FOR CAPS, AND THUS OBTAINED SEAL RINGS - An apparatus for forming an object from plastics material includes a forming arrangement having a recess for forming an edge zone of the object, the recess extending around an internal region of the forming arrangement and a conduit cooperating with a piston device to supply the plastics material to the recess, the conduit leading into the internal region into a position contiguous with the recess. | 2013-09-05 |
| 20130230616 | SPLIT THREAD INSERT - A split thread insert is disclosed with integral cooling channels utilized for the continuous internal circulation of cooling fluid around a molding surface of the split thread insert, wherein the molding surface forms a neck area of a preform during an injection molding process. The molding surface of the split thread insert is semi-circular with a profile corresponding with a threaded area of the preform. The split thread insert is assembled from two or more cut pieces, wherein at least one of the cut pieces includes a curved groove formed therein proximate the molding surface for forming a curved cooling fluid channel when the cut pieces are joined to form the split thread insert. The cooling fluid channel includes a flow diverter positioned therein for defining a portion of a continuous cooling fluid circuit of the split thread insert. | 2013-09-05 |
| 20130230617 | Valve Bushing for an Injection Molding Apparatus - A valve bushing having an actuator portion and a pin guiding component is disclosed. The actuator portion has a cup-shaped body with a stepped bore that defines a chamber in which a piston for opening and closing a valve gate disposed, and also defines a transfer bore extending through a base portion of the cup-shaped body. A stand-off member elevates the cup-shaped body from the manifold. The pin guiding component defines a sealing bore that extends between a body portion and a boss that extends rearward from the body portion. The boss is received in the transfer bore of the cup-shaped body to define a thermal transfer area between the pin guiding component and the actuator portion that is spaced apart from the manifold, and the actuator portion is located relative to the pin guiding component by engagement between the pin guiding component and the stand-off member. | 2013-09-05 |
| 20130230618 | APPARATUS FOR MANUFACTURING A SEMICONDUCTOR PACKAGE - An apparatus for manufacturing a semiconductor package includes at least a first mold, a rotator, and a driver. The first mold has a first mold section, a second mold section, and at least one cavity formed when the first mold section and the second mold are brought together. The rotator is coupled to the first mold, and the driver is between the first mold and a rotating axis of the rotator. The driver supplies a molding resin into the cavity based on centrifugal force generated when the rotator rotates on the rotating axis. | 2013-09-05 |
| 20130230619 | ENHANCED BIOAVAILABLE IODINE MOLECULES - This invention relates to supplementation of the diets of domesticated animals (livestock and poultry) with iodine in an enhanced bioavailable manner, that is to say the iodine is more available to the animal than when using conventional sources of iodine, such as calcium iodate. The supplementary compound are alpha amino acid metal iodide complexes. | 2013-09-05 |
| 20130230620 | AGE-TAILORED NUTRITIONAL FORMULA WITH PARTICULARLY ADAPTED CALORIC DENSITY FOR INFANTS AND CHILDREN - Nutritional formulae which are specifically designed to address the needs of infants and young children up to at least 2 years of age. In particular, the inventionv provides a set of nutritional compositions for infants and young children, each nutritional composition having an age-specific caloric density. The set of the invention is specifically aimed at providing long-term benefits to the infants and young children such as reducing obesity and reducing cardiovascular diseases later in life. | 2013-09-05 |
| 20130230621 | ROYAL JELLY SOLUTION AND METHOD FOR PRODUCING SAME - A method for producing a royal jelly solution, comprising subjecting an aqueous royal jelly suspension to an enzymatic reaction catalyzed by an enzyme having cysteine protease activity at 20° C.˜70° C. | 2013-09-05 |
| 20130230622 | LAMINATED FLAVORED PASTRY AND METHOD OF MANUFACTURING THEREOF - A method of manufacturing an edible product, a laminated dough composition and an edible product are provided. The method includes mixing ingredients including starch, gluten, a plasticizer, fat and leavening into a pastry dough composition. A flavored fat composition is prepared by mixing ingredients comprising fat, at least one flavor additive and at least one filling. The flavored fat composition is then applied to a surface of the pastry dough composition. Both compositions are folded and sheeted to form a laminated dough. The laminated dough is then formed into pieces, which are proofed and then baked. A laminated dough composition, and an edible product itself, is provided that comprises a plurality of layers of a flavored fat interposed between a plurality of layers of a pastry dough, the pastry dough composition comprising starch, gluten, a plasticizer, fat and leavening; the flavored fat composition comprising fat, at least one flavor additive and at least one filling. | 2013-09-05 |
| 20130230623 | MILK PRODUCT AND PREPARATION METHOD - The invention relates to a low lactose milk product where the milk protein is hydrolyzed by a protease without negatively affecting the organoleptic properties and appearance of the milk product. The invention also relates to a process for preparing a protein hydrolyzed milk product with a low lactose content. | 2013-09-05 |
| 20130230624 | TREATMENT OF PLANT BIOMASS - Lignocellulosic biomass is treated to increase accessibility of the material to enzymes and fermentative processes. Accessibility is increased by physical pre-treatment of the biomass using ultrasound and/or microwave and/or cool plasma. The physical treatments degrade the waxy cuticle of the biomass facilitating enzyme accessibility to cellulose and hemicellulose for conversion to utilizable matter, in nutritive and chemical or biofuel industries. These physical treatments improve enzyme accessibility to cellulose and hemicellulose, for enhancing conversion into a range of feed stocks amenable to further processing. | 2013-09-05 |
| 20130230625 | PAD WITH COVERING FILLED WITH PRODUCT TO BE EXTRACTED, ASSEMBLY OF A FIRST AND A SECOND PAD AND METHOD FOR PREPARING A SMALL OR LARGE AMOUNT OF BEVERAGE - A pad with a covering filled with product to be extracted and/or to be dissolved, wherein, in use, a fluid such as water is supplied under pressure to the pad, so that the fluid is pressed through the pad for obtaining a beverage which, thereupon, leaves the pad. The pad is provided with a spout opening for generating, with the spout opening, a jet of the beverage which leaves the pad for obtaining the fine bubble froth layer on the beverage with the aid of the beverage. | 2013-09-05 |
| 20130230626 | Electric Skillet with Magnetic Self-Reversing Stirrer That is Removable - A cooking skillet that provides a unique automatic stirring system for continuously stirring foods during cooking. The cooking skillet comprises a base, a receptacle, a heating element, and an automatic stirring system. The automatic stirring system comprises a stirring wand located in the receptacle and a bracket located in the base. The stirring wand and the bracket are attracted to each other through magnetic forces that provide sufficient magnetism to attract one to the other. A motor is attached to the bracket by a connecting rod and provides the means to rotate the bracket in a clockwise direction. The magnetism between the magnets in the bracket and the magnets in the stirring wand forces the stirring wand to rotate in connection with the bracket. During rotation, the stirring wand is designed to mix the food contained within the receptacle. A controlling box is used to control the power to the motor and provides a resisting sensor or reversing circuit to reverse the rotational direction of the stirring system as necessary. | 2013-09-05 |
| 20130230627 | APPARATUS AND METHODS RELATING TO DISPENSATION FROM BEVERAGE MACHINES - The present invention provides a device ( | 2013-09-05 |
| 20130230628 | INSTANT BEVERAGE PRODUCT - The present invention relates to a method for the production of instant beverage granules which, upon reconstitution with water, form a foamy upper surface. The method makes use of a porous base powder to which the present invention also relates. | 2013-09-05 |
| 20130230629 | METHOD OF MANUFACTURING PROTEIN BEVERAGES AND DENATURIZING LOOP APPARATUS AND SYSTEM - A method and system for forming a beverage mixture comprising protein is disclosed. The method comprises heating the beverage in a heat exchanger, transferring the beverage to a hold loop located outside of the heat exchanger, and denaturizing the protein within the hold loop for a residence time, after the beverage is heated in the heat exchanger such that the denaturizing occurs outside of the heat exchanger to prevent fouling of the heat exchanger. The system comprises a beverage forming tank, a heat exchanger for heating the beverage, and a first hold loop separate from the heat exchanger, which is configured to hold the beverage for a residence time to denaturize a protein in the beverage. | 2013-09-05 |
| 20130230630 | OIL OR FAT COMPOSITION - A fat or oil composition comprising from 0.02 to 0.65 mass % of a free type triterpene alcohol and 0.18 mass % or less of a γ-oryzanol. | 2013-09-05 |
| 20130230631 | POWDER MIX - A powder mix containing soluble pectin which easily dissolves in cold water at about 5° C. is provided. A powder mix including pectin in which the calcium content in pectin has been adjusted to 500 ppm or less is provided. The cold water-solubility of pectin is further enhanced by adjusting the pectin such that 80% by mass or more has a particle size of 150 μm or less, or by dissolving the pectin together with one kind or two or more kinds of sodium salts, potassium salts, and magnesium salts. | 2013-09-05 |
| 20130230632 | PROCESS FOR PRODUCING LACTOSE-FREE MILK - The invention concerns a process for producing lactose-free or substantially lactose-free milk, preferably without addition of water, and the product obtainable by the process. The process comprises the steps of:
| 2013-09-05 |
| 20130230633 | FRUIT AND VEGETABLE PRESERVATION PROCESS - An HPP method for preserving a food item such as a fruit or vegetable may include the steps of: (a) placing a prepared fruit and/or vegetable in a container having a capacity less than about two gallons; (b) filling the container with a pH modifying solution or sauce to establish a pH in the container in the range of about 2 to about 6, and preferably about 4; (c) dearation; (d) sealing the container; and (e) applying pressure to the container in the range of about 2,000 to about 120,000 psi, preferably about 90,000 psi, for a time period in the range of about 1 to about 20 minutes, preferably about 5 minutes at a temperature in the range not lower than freezing and not greater than about 230° F. | 2013-09-05 |
| 20130230634 | OIL AND FAT COMPOSITION AND METHOD OF PRODUCING THEREOF - The present invention addresses the problem of developing an oil and fat composition which can be used for accelerating or omitting tempering in production process of chocolate, and is capable of maintaining StOSt type triglyceride crystals in a fine state stably, shows good dispersibility, and offers ease of handling such as subdivided packaging or the like. | 2013-09-05 |
| 20130230635 | PERONOSPORA RESISTANCE IN SPINACIA OLERACEA - The present invention relates to a spinach plant which may comprise a single dominant gene which confers resistance to | 2013-09-05 |
| 20130230636 | MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENING AGENT AND OR MOISTURIZING AGENT, METHOD FOR CONTROLLING CONTENT OF SOFTENING AGENT AND OR MOISTURIZING AGENT IN THE MEDICAL MATERIAL, AND METHOD FOR PRODUCING THE MEDICAL MATERIAL FOR IN VIVO IMPLANTATION - A medical material for in vivo implantation contains a bioabsorbable material containing a softening agent and/or a moisturizing agent and a non-bioabsorbable porous base material, in which the content of a softening agent and/or a moisturizing agent is controlled less than 20 wt %; a method for controlling this content; and a method for producing a medical material for in vivo implantation are provided. | 2013-09-05 |
| 20130230637 | MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENING AGENT AND OR MOISTURIZING AGENT, METHOD FOR CONTROLLING CONTENT OF SOFTENING AGENT AND OR MOISTURIZING AGENT IN THE MEDICAL MATERIAL, AND METHOD FOR PRODUCING THE MEDICAL MATERIAL FOR IN VIVO IMPLANTATION - A medical material for in vivo implantation contains a bioabsorbable material containing a softening agent and/or a moisturizing agent and a non-bioabsorbable porous base material, in which the content of a softening agent and/or a moisturizing agent is controlled less than 20 wt %; a method for controlling this content; and a method for producing a medical material for in vivo implantation are provided. | 2013-09-05 |
| 20130230638 | MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENING AGENT AND/OR MOISTURIZING AGENT, METHOD FOR CONTROLLING CONTENT OF SOFTENING AGENT AND/OR MOISTURIZING AGENT IN THE MEDICAL MATERIAL, AND METHOD FOR PRODUCING THE MEDICAL MATERIAL FOR IN VIVO IMPLANTATION - A medical material for in vivo implantation contains a bioabsorbable material containing a softening agent and/or a moisturizing agent and a non-bioabsorbable porous base material, in which the content of a softening agent and/or a moisturizing agent is controlled less than 20 wt %; a method for controlling this content; and a method for producing a medical material for in vivo implantation are provided. | 2013-09-05 |
| 20130230639 | ROTATABLE SUPPORT ELEMENTS FOR STENTS - Various embodiments of methods and devices for coating stents are described herein. The method includes applying a coating composition to the stent; rotating the stent with a rotatable element supporting at least a portion of the stent; and applying at least one pulse to the rotatable element during the stent coating process. | 2013-09-05 |
| 20130230640 | CERAMIC LAYERED MEDICAL IMPLANT - A new composition and medical implant made there from comprises a thick diffusion hardened zone, and layered ceramic surface. Orthopedic implants comprising the new composition, methods of making the new composition, and methods of making orthopedic implants comprising the new composition are disclosed. | 2013-09-05 |
| 20130230641 | COATING METHOD AND COATING APPARATUS - In a coating apparatus | 2013-09-05 |
| 20130230642 | METHOD OF MANUFACTURING ACTIVE RETARDER AND METHOD OF MANUFACTURING DISPLAY APPARATUS HAVING THE SAME - A method of manufacturing an active retarder includes forming a first substrate, forming a second substrate, and forming a liquid crystal layer between the first substrate and the second substrate. The forming of the first and second substrates is performed by a roll-to-roll process. | 2013-09-05 |
| 20130230643 | ATOMIC LAYER DEPOSITION ENCAPSULATION FOR ACOUSTIC WAVE DEVICES - Acoustic wave devices and methods of coating a protective film of alumina (Al | 2013-09-05 |
| 20130230644 | Coatings for SOFC Metallic Interconnects - Various methods of treating a chromium iron interconnect for a solid oxide fuel cell stack and coating the interconnect with a ceramic layer are provided. | 2013-09-05 |
| 20130230645 | METHOD OF PRODUCING A FLUORORESIN COMPOSITION AND ELECTRICAL WIRE - A method of producing a fluororesin composition includes copolymerizing at least tetrafluoroethylene with hexafluoropropylene so that a melt flow rate at 372 degree C. of the copolymer formed in the copolymerization changes from 0.05-5.0 grams/10 minutes to 10-60 grams/10 minutes. The tetrafluoroethylene/hexafluoropropylene copolymer can be used as a coating on an electrical wire. | 2013-09-05 |
| 20130230646 | METHOD AND APPARATUS FOR SOLID-STATE MICROBATTERY PHOTOLITHOGRAPHIC MANUFACTURE, SINGULATION AND PASSIVATION - A method for producing a thin film lithium battery is provided, comprising applying a cathode current collector, a cathode material, an anode current collector, and an electrolyte layer separating the cathode material from the anode current collector to a substrate, wherein at least one of the layers contains lithiated compounds that is patterned at least in part by a photolithography operation comprising removal of a photoresist material from the layer containing lithiated compounds by a process including a wet chemical treatment. Additionally, a method and apparatus for making lithium batteries by providing a first sheet that includes a substrate having a cathode material, an anode material, and a LiPON barrier/electrolyte layer separating the cathode material from the anode material; and removing a subset of first material to separate a plurality of cells from the first sheet. In some embodiments, the method further includes depositing second material on the sheet to cover the plurality of cells; and removing a subset of second material to separate a plurality of cells from the first sheet. | 2013-09-05 |
| 20130230647 | PERPENDICULAR MAGNETIC RECORDING MEDIUM AND METHOD OF MANUFACTURING THE SAME - A perpendicular magnetic recording medium comprises a magnetic recording layer that records a signal, an underlayer formed of Ru or Ru compound below the magnetic recording layer, a non-magnetic layer formed of a non-magnetic material below the underlayer to control crystal orientation of the underlayer, a soft magnetic layer provided below the non-magnetic layer, and a substrate on which the magnetic recording layer, the underlayer, the non-magnetic layer, and the soft magnetic layer are formed. The non-magnetic layer comprises a first non-magnetic layer formed above the soft magnetic layer and a second non-magnetic layer formed above the first non-magnetic layer. The first non-magnetic layer is formed of amorphous Ni compound while the second non-magnetic layer is formed of crystalline Ni or crystalline Ni compound. | 2013-09-05 |
| 20130230648 | KIT OF PARTS FOR CURABLE COATING COMPOSITION - The invention relates to a kit of parts for preparation of a crosslinkable coating composition comprising a) a binder module comprising a film-forming binder comprising crosslinkable functional groups A, b) a crosslinker module comprising a crosslinker comprising at least two functional groups B capable of reacting with the crosslinkable functional groups A of the binder, c) a thermal activator module comprising one or more components which exhibit an accelerating effect on the reaction between functional groups A and B of the mixture of the binder module and the crosslinker module, d) an ultraviolet activator module comprising one or more components which after irradiation with ultraviolet light exhibit a greater accelerating effect on the reaction between functional groups A and B of the mixture of the binder module and the crosslinker module than before irradiation with ultraviolet light. | 2013-09-05 |
| 20130230649 | Process for Tinting Articles, and Tintable Compositions for Use in Said Process - The present invention concerns a process for tinting an article, comprising providing an article having a substrate and an ink receptive coating applied thereon, applying on said ink receptive coating a tinting solution containing at least one dye through ink jet printing, said ink receptive coating being obtained by curing an ink receptive coating composition comprising the at least partial hydrolyzate of a component A consisting of one or more compounds containing at least one polyalkylene oxide segment having at least three alkylene oxide units, said segment being chosen from polyethylene oxide, polypropylene oxide and polyethylene oxide-co-polypropylene oxide segments and at least one —Si(X)n hydrolyzable group, in which n is an integer ranging from 1 to 3, and the X groups, identical or different, represent OH groups or precursors of OH groups, and optionally, at least one silane component B, components A and optional component B being chosen such that a cross-linked structure is generated upon polymerization of said composition. The invention also concerns an ink receptive coating composition for use in the above process. | 2013-09-05 |
| 20130230650 | METHOD FOR MANUFACTURING OPTICAL PRINTED CIRCUIT BOARD - A method for manufacturing an optical printed circuit board (OPCB) includes: providing a substrate having a loading surface; forming a first cladding solvent layer on the loading surface by a spin coating method; solidifying the first cladding solvent layer to form a first cladding layer; forming a core solvent layer on the first cladding layer through the spin coating method; solidifying the core solvent layer to form a core layer; forming optical waveguide patterns on the core layer by a roller pressing method; forming a second cladding solvent layer on the core layer through the spin coating method; and solidifying the second cladding solvent layer to form the second cladding layer. | 2013-09-05 |
| 20130230651 | FILM FORMATION APPARATUS AND FILM FORMATION METHOD USING THE SAME - A film formation apparatus includes a processing chamber configured to keep an inside thereof in a decompressed state, a gas introduction path configured to introduce a predetermined source gas into the processing chamber, a catalyst provided inside the processing chamber in such a way that the source gas introduced through the gas introduction path comes into contact with a surface of the catalyst or passes near the surface thereof, a power supply unit configured to apply energy to the catalyst to heat the catalyst, a detector provided below the catalyst, and a controller configured to detect an electric current flowing through the detector or a voltage from the detector and to judge a contact state between the catalyst and the detector. | 2013-09-05 |
| 20130230652 | RUTHENIUM FILM FORMATION METHOD AND COMPUTER READABLE STORAGE MEDIUM - A ruthenium film formation method includes placing and heating a substrate inside a process chamber, and supplying a ruthenium compound gas and a decomposing gas for decomposing this compound into the process chamber while periodically modulating at least one of flow rates of these gases, to form a plurality of steps having gas compositions different from each other. Without purging an interior of the process chamber between these steps, the method includes causing the gases to react with each other on the substrate thus heated, thereby forming a ruthenium film on the substrate. | 2013-09-05 |
| 20130230653 | USE OF A TRANSPORT COATING TO APPLY A THIN COATED LAYER - It has now been determined that a first coating layer may be applied to a substrate by a first coating die in a much thinner layer than its rheological properties and/or surface properties would normally allow. This is accomplished by using a second coating fluid dispensed from a second coating die acting as a “dynamic liquid squeegee” to transport, spread, even, or meter the first coating layer on the substrate by varying a gap between the second coating die and the substrate. | 2013-09-05 |
| 20130230654 | METHODS FOR MARKING GOLF CLUB FERRULE - Described herein are methods of creating markings on a golf club ferrule, some of which comprising providing a polymeric ferrule body having a first color; painting at least a portion of the ferrule body with a paint material, the paint material having a second color that is different than the first color, such as with a high contrast; and removing one or more portions of the paint material from the ferrule body, such as by laser engraving, to reveal respective portions of the first color, thereby forming one or more markings on the ferrule. | 2013-09-05 |
| 20130230655 | Particulate Materials for Acoustic Texture Material - An acoustic texture material adapted to be dispensed from an aerosol assembly using bi-phase propellant materials to form a textured coating on drywall material such that the textured coating substantially matches a pre-existing acoustic texture material on the drywall material. The acoustic texture material has a base portion capable of existing in a flowable state and a hardened state and a particulate portion comprising discrete particles that are visible to an unaided eye. The particulate portion is comprised of at least one of urethane foam and melamine foam. The base portion is capable of securing the particles to the drywall material when the base portion is in the hardened state. | 2013-09-05 |
| 20130230656 | Polyheterosilxoanes For High Refractive Index Materials - Polyheterosiloxane compositions are disclosed containing at least 70% by weight of the following components: (A) a first metal (M1) selected from Ti, Zr, or Zn, (B) a second metal (M2) selected from a non-lanthanide metal, (C) siloxy units having the formula R | 2013-09-05 |
